LEXICON PHARMACEUTICALS, INC. (LXRX) Gross margin 2017–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
99.4%FY2025 · since FY2017: 88.0% → 99.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 99.4% | +9.7 pp |
| FY2024 | 89.7% | -2.6 pp |
| FY2023 | 92.3% | — |
| FY2020 | 91.8% | +1.8 pp |
| FY2019 | 90.0% | -0.6 pp |
| FY2018 | 90.6% | +2.6 pp |
| FY2017 | 88.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LXRX financial trends
LXRX RevenueLXRX Net incomeLXRX Net marginLXRX Gross profitLXRX Operating incomeLXRX Operating marginLXRX Operating cash flowLXRX Free cash flowLXRX Capital expendituresLXRX Return on equityLXRX Stock buybacksLXRX Dividends paidLXRX Total assetsLXRX Total liabilitiesLXRX Shareholders’ equityLXRX overview →